Babcock International hums to 8yr high as analysts warm to Cavendish Nuclear arm

Babcock International shares rose nearly 3% to a high not seen since 2017 after analysts highlighted the growth potential of its Cavendish Nuclear business. JPMorgan raised its price target to £11, citing expected EPS growth of 10% over the next five years, driven by Cavendish's expansion in clean energy and nuclear decommissioning, supported by a £1 billion order backlog and a £5 billion pipeline; Cavendish is targeting revenue of £600 million by 2030, up from approximately £320 million in the 2025 financial year.

Analysis

Babcock International PLC's shares surged nearly 3% to 884.8p, reaching an eight-year high, driven by positive analyst sentiment towards its Cavendish Nuclear division. JPMorgan increased its price target for Babcock to £11 from £10, forecasting an average EPS growth of 10% for the next five years and raising EPS forecasts by 1-4% for the next three years, citing high visibility and reducing execution risk. This optimism stems from an "upbeat" teach-in on Cavendish Nuclear, which constituted 7% of group sales last year and is targeting revenue of approximately £600 million by 2030, up from circa £320 million in FY2025. Cavendish Nuclear, a key non-military unit involved in all 36 UK nuclear licensed sites, boasts a £1 billion order backlog and a £5 billion pipeline, including £1 billion in active bids. The division's Clean Energy segment, accounting for 38% of its revenue, is poised to be a primary growth engine, with sales projected to rise from £120 million to £300 million, aligning with the UK's goal to expand nuclear capacity from 6GW to 24GW by 2050. Cavendish also benefits from defence contracts, including submarine support through AUKUS and a partnership with HII. The division operates with margins of 12%, above the group average, and a favorable risk profile with 40% of contracts on a cost-plus basis. Analysts like Peel Hunt view Cavendish as a "quality business with significant upside potential," while Jefferies highlights its "limited-risk, higher-margin activities" and ability to deliver growth driven by secular trends, despite a potential peak in infrastructure work. JPMorgan also noted Babcock is "one of the cheapest European defence stocks" in its coverage, suggesting a valuation re-rating potential.

Key Decisions for Investors

• Investors should consider the significant growth trajectory of Babcock's Cavendish Nuclear arm, particularly its exposure to the expanding UK clean energy market and nuclear decommissioning, which is underpinned by a strong order book and government support.
• Given the analysts' revised earnings forecasts, a projected 10% average EPS growth over five years, and Babcock's comparatively low valuation within the European defence sector, the stock may offer an attractive entry point for long-term value appreciation.
• Monitor the execution of Cavendish Nuclear's strategic initiatives, including its ability to secure contracts within the £15 billion addressable SMR market by 2030 and the broader £25-30 billion UK nuclear build-out, as well as developments in the AUKUS programme impacting its defence-related nuclear operations.